Please login to the form below

Not currently logged in

Sanofi appoints Meeker CEO of Genzyme

Current chief operating officer of Genzyme, David Meeker, will take over as CEO of the company from November 1

Current chief operating officer of Genzyme, David Meeker, will take over as CEO of the company from November 1.

He was appointed by France-based pharmaceutical company Sanofi who purchased Genzyme in April 2011 for about $20bn.

Former Genzyme CEO, Henri A Termeer, who had spent 26 years in the position, left Genzyme following the takeover. The company had since been without a CEO until Meeker's appointment.

Christopher A Viehbacher, CEO of Sanofi, said: "After working closely with David over the past six months, I am confident that he is the best person to lead Genzyme. David's commitment to employees, physicians and patients has been a key success factor in the successful integration of Genzyme as part of the Sanofi Group."

Under Meeker's leadership, Genzyme will incorporate the rare disease business and the multiple sclerosis franchise.

Previous Genzyme divisions - renal, biosurgery and oncology - have been integrated within the existing Sanofi portfolio.

Meeker joined Genzyme in 1994 as medical director to work on the cystic fibrosis gene therapy programme. Other positions Meeker held at Genzyme include president of the global rare disease business.

25th October 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....